These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19910448)

  • 1. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
    Subramaniam RM; Truong M; Peller P; Sakai O; Mercier G
    AJNR Am J Neuroradiol; 2010 Apr; 31(4):598-604. PubMed ID: 19910448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
    Rabalais AG; Walvekar R; Nuss D; McWhorter A; Wood C; Fields R; Mercante DE; Pou AM
    Laryngoscope; 2009 Jun; 119(6):1120-4. PubMed ID: 19358193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET.
    Hoshikawa H; Mitani T; Nishiyama Y; Yamamoto Y; Ohkawa M; Mori N
    Auris Nasus Larynx; 2009 Apr; 36(2):192-8. PubMed ID: 18606510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
    Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [F-18 fluorodeoxyglucose positron emission tomography in evaluation of tumors of the ENT area: personal results and review of the literature].
    Kresnik E
    Wien Med Wochenschr; 2002; 152(11-12):259-64. PubMed ID: 12138652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorodeoxyglucose positron emission tomography, a new technique for increasing the detection rate of coincident thyroid cancer in head and neck oncology.
    Stokkel MP; de Klerk JM; Hordijk GJ
    Eur Arch Otorhinolaryngol; 2000 Dec; 257(10):552-4. PubMed ID: 11195035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma].
    Haenggeli CA; Dulguerov P; Slosman D; Becker M; Bang P; Allal A; Guyot JP; Lehmann W
    Schweiz Med Wochenschr Suppl; 2000; 116():8S-11S. PubMed ID: 10780061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-therapeutic imaging strategies and follow-up in head and neck malignant tumours].
    Aschenbach R; Esser D
    HNO; 2010 Aug; 58(8):749-55. PubMed ID: 20640391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
    Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
    Goerres GW; Schmid DT; Grätz KW; von Schulthess GK; Eyrich GK
    Oral Oncol; 2003 Sep; 39(6):547-51. PubMed ID: 12798396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography.
    Horiuchi C; Taguchi T; Yoshida T; Nishimura G; Kawakami M; Tanigaki Y; Matsuda H; Mikami Y; Oka T; Inoue T; Tsukuda M
    Auris Nasus Larynx; 2008 Mar; 35(1):103-8. PubMed ID: 17825512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
    Hanasono MM; Kunda LD; Segall GM; Ku GH; Terris DJ
    Laryngoscope; 1999 Jun; 109(6):880-5. PubMed ID: 10369275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) in ORL and pulmonary oncology].
    Barghouth G; Allaoua M; Goerres GW
    Rev Med Suisse Romande; 2000 Jun; 120(6):535-42. PubMed ID: 11014099
    [No Abstract]   [Full Text] [Related]  

  • 14. [Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor].
    Schipper JH; Schrader M; Arweiler D; Müller S; Sciuk J
    HNO; 1996 May; 44(5):254-7. PubMed ID: 8707630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference].
    Kohlfürst S; Markitz M; Raunik W; Eckel HE; Kresnik E; Hausegger K; Salzwimmer M; Gaggl A; Chiari F; Lind P
    Laryngorhinootologie; 2009 Feb; 88(2):84-90. PubMed ID: 19219754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
    J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ( 18 ) F-FLT PET and ( 18 ) F-FDG PET for detection of cervical lymph node metastases in head and neck cancers.
    Hoshikawa H; Kishino T; Mori T; Nishiyama Y; Yamamoto Y; Inamoto R; Akiyama K; Mori N
    Acta Otolaryngol; 2012 Dec; 132(12):1347-54. PubMed ID: 22992199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
    Fischbein NJ; AAssar OS; Caputo GR; Kaplan MJ; Singer MI; Price DC; Dillon WP; Hawkins RA
    AJNR Am J Neuroradiol; 1998 Aug; 19(7):1189-96. PubMed ID: 9726451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
    Pai M; Park CH; Suh JH; Koh JH
    Clin Nucl Med; 1999 Jul; 24(7):495-500. PubMed ID: 10402001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.